Neuro-oncology includes cancers of the brain and nervous system.

The Neuro-oncology Disease Site Group (Neuro-oncology Cancer DSG) produced evidence-based reports to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances. Reports produced by this group are available below.

Malignant Glioma

• Adjuvant Systemic Chemotherapy, Following Surgery and External Beam Radiotherapy, for Adults with Newly Diagnosed Malignant Glioma
  9-2 EBS: November 2006 Update
  
  • Practice Guideline
  • Evidence-Based Series
• Radiotherapy for Newly Diagnosed Malignant Glioma in Adults
  9-3 EBS: November 2005 Update
  
  • Practice Guideline
  • Evidence-Based Series
• Gliadel® Wafers in the Treatment of Malignant Glioma
  9-7 EBS: August 2006
  
  • Practice Guideline
  • Evidence-Based Series
• Use of Temozolomide in the Treatment of Newly Diagnosed or Recurrent Malignant Glioma
  9-5 ES
  September 2005 : This document has been retired and is no longer available. Current recommendations for the use of temozolomide in newly-diagnosed malignant glioma are reflected in 9-2 EBS Adjuvant Systemic Chemotherapy, Following Surgery and External Beam Radiotherapy, for Adults with Newly Diagnosed Malignant Glioma and 9-3 EBS Radiotherapy for Newly Diagnosed Malignant Glioma in Adults.
  
• Surgical Management of Malignant Glioma
  9-8 ES: July 2004
  
  • Summary
  • Summary & Full Report

Other

• Management of Single Brain Metastases
  9-1 EBS Version 2.2006: August 2006
  
  • Practice Guideline
  • Evidence-Based Series
• The Use of Prophylactic Anticonvulsants in Patients with Brain Tumours
  9-4 EBS: October 2006
  
  • Practice Guideline
  • Evidence-Based Series
• Malignant Extradural Spinal Cord Compression: Diagnosis and Management
  9-9 ES: January 2004 Update
  
  • Summary
  • Summary & Full Report

Page Updated: 2008 Mar 31